1. Introduction
Disturbances of the endoplasmatic reticulum (ER) homeostasis cause protein folding or misfolding in the ER lumen, a condition called ER stress, which triggers unfolded protein response (UPR) [
1]. A paradox of the UPR pathway is that it leads to a response with simultaneous activation of cell survival and pro-apoptotic pathways. Under those ER stress conditions, activation of the UPR reduces unfolded protein load through several pro-survival mechanisms, including the expansion of the ER membrane, the selective synthesis of key components of the protein folding and the quality control machinery and the attenuation of the influx of proteins into the ER [
2]. When ER stress is not mitigated and the homeostasis is not restored, the UPR triggers apoptosis. There are three predominant and unique signaling transduction mechanisms among the UPR signaling pathways: inositol-requiring enzyme 1(IRE1), protein kinase RNA (PKR)-like kinase (PERK) and activating transcription factor 6 (ATF6) [
3,
4]. The IRE1 endoribonuclease is activated through dimerization and transphosphorylation. This leads to the removal of a 26-nucleotide intron from the premature unmodified form of XBP1 (XBP1-u) gene to produce the unmodified XBP1 (XBP1-s) form [
5]. XBP1-s moves to the nucleus and induces UPR-responsive genes. XBP1-s is usually regarded as a reliable marker for the induction of the IRE1 pathway of the UPR, because XBP1 is unmodified exclusively under ER stress conditions [
6]. However, if ER stress is excessive or prolonged, the UPR fails, and cellular apoptosis is induced by activation of CCAAT-enhancer-binding-protein homologous protein (CHOP), Jun N-terminal kinase, and cleaved caspase 3 [
7,
8].
Early embryonic stages are (one of) the most critical periods of the mammalian development [
9]. These early stages involve various morphological and biochemical changes related to genomic activity and a complex set of physiological processes, many of which are still unknown [
10]. These processes are controlled by several molecular mechanisms and pathways that have a fundamental role in the coordination of homeostatic and metabolic processes [
11,
12]. Within
in vitro systems, disturbances in the embryo's culture environment after fertilization can have detrimental effects on embryonic gene expression [
13] which, in turn, can have serious implications for the normality of the blastocyst’s physiology. However, the exact influence of
in vitro culture conditions during each of these critical events/steps is still unknown.
Recent studies in several species have shown that ER stress in the embryo impairs embryo developmental competence [
14,
15] and that stress relief can improve the embryo quality [
15,
16,
17,
18]. In the bovine species, the supplementation of the
in vitro culture (IVC) medium with tauroursodeoxycholic acid (TUDCA) - a bile acid that acts as a potential chemical chaperone against ER stress
in vitro [
19] - has been an alternative to relieve ER stress and improve the developmental competence in embryos cloned by somatic cell nuclear transfer [
16] and embryos subjected to high O2 tension [
20].
Nevertheless, little is known about the effects of ER stress on cryogenic tolerance of embryos generated
in vitro [
21]. It is studied that the
in vitro produced embryo (IVPE) has distinct characteristics when compared to its counterpart produced
in vivo. These differences between IVPE and
in vivo derived from embryos which involve morphological [
22] and molecular aspects that affect the embryo quality and development [
23] decreasing cryo-tolerance and pregnancy rates [
24]. Therefore, maintaining cell viability after warming is a prerequisite to achieve high outcomes within cryopreservation protocols. To help bridge this gap between IVPE and
in vivo derived from embryos to improve post-cryopreservation results, the ER stress could be an alternative target for pharmacological approach.
We hypothesized that supplementation of TUDCA during IVC, decreases the endoplasmic reticulum stress of bovine embryos and improves the cryogenic competence of the embryo related to re-expansion and post-warming hatching rate. Thus, the present study aimed: 1) to evaluate the developmental competency of bovine embryos after being treated with TUDCA in IVC; 2) to investigate the effects of TUDCA treatment in IVC on subsequent developmental competency post-warming of the vitrified blastocysts.
3. Discussion
Developing embryos may be subjected to several sources of exogenous stress in
in vitro culture system [
15,
31,
32,
33]. These include oscillating temperature, DNA damage or DNA damaging agents, osmotic stress, and availability of organic osmolytes, oxygen and oxidative stress, hyperglycemia and carbon substrate availability, hyperlipidemia and oxidized lipids, calcium ionophores, cytokines, amino acid deprivation, insulin signaling, and serum components [
15,
31,
32,
33]. Cold stress associated with cryopreservation affects embryo development and gene regulation [
22,
24,
34]. These adverse factors negatively impact ER functions and protein synthesis and folding, resulting in the activation of ER stress and the UPR signaling pathways in
in vitro produced embryo [
14,
15,
16,
17]. Furthermore, there is evidence that IVPEs are more sensitive to cryopreservation than
in vivo derived from embryos [
48,
50] and that this reduced cryotolerance which may be associated with the high lipid content present in the cytoplasm as well as the lipid profile of the cell membrane of these embryos [
23,
24,
48]. Although TUDCA has been demonstrated to exert efficient cytoprotective activity in relieving ER stress [
17,
18,
20,
21], recent studies reported on its new potential and molecular modes of action as a weight-reducing agent, modulating lipid metabolism through or independently of ER modulation [
51,
52]. In the current study, we demonstrated that 200 µM of TUDCA during IVC enhanced the cryotolerance of bovine embryo through the putative modulation of ER and oxidative stress. At 24- and 48-hours post-warming, embryos treated with TUDCA during IVC, had an increase in hatching rate when compared to Control group.
Unlike our results, it was reported in cattle that 10 µM TUDCA was able to improve cryotolerance of embryos after vitrification, increasing hatching rates and decreasing the number of apoptotic cells in the embryo 48-hours post-warming [
21]. In this way, the action of TUDCA seems to be highly dependent on the complex combination of variables such as the species, breed, the used concentration, and the
in vitro culture conditions.
When we evaluated the 96 markers of transcript abundance in the hatched embryos post-warming, TUDCA treatment induced the decreasing of the mRNA abundance related to ER stress and lipid metabolism pathways. An increase in the mRNA abundance related to antioxidant activity was also observed in embryos in the T200 group. After warming post-vitrification, hatched blastocysts treated with TUDCA showed less mRNA abundance for HSPA5 and XBP1. In several species, the increasing of XBP1-s expression is widely used as a molecular marker of ER stress
in vivo and
in vitro [
53,
54]. The increasing mRNA abundance for XBP1-s and HSPA5 was associated with the low competence of embryonic development in several species [
18,
20,
50]. In addition, after warming vitrified embryos treated with TUDCA showed a change in the expression of antioxidants, with high mRNA abundance for CAT, GPX1, NFE2L2 and PRDX1, and less abundance for GLRX2. NFE2L2 is a promising target against oxidative stress, responsible for inducing the expression of several endogenous cytoprotective enzymes [
55,
56].
In vitro study with the human neuroblastoma SH-SY5Y cell line, observed that TUDCA prevented oxidative stress through the highest expression of NRF2, DJ-1, and antioxidant enzymes heme oxygenase-1 (HO-1) and glutathione peroxidase (GPx) [
57], corroborating with our results. The previous study has shown that embryos produced
in vivo and cryopreserved undergo greater oxidative stress when compared to embryos that have not been subjected to cryopreservation [
34]. In the conditions of this paper, the treatment with TUDCA could have prevented high levels of oxidative stress in vitrified embryos cultured after warming. Collectively, those data could partially explain the higher cell competence to hatch observed with TUDCA treatment, since a mitigated stress (ER and oxidative) improves the cellular activity.
The hatched embryos also modulated markers related to the metabolism. While the mRNA abundance for PLIN3 and SREBF2 decreased, the abundance for G6PD and SLC2A3 were increased with TUDCA treatment.
The reduced post-warming cell viability is also associated with the abnormal amount and/or the type of lipids in the blastomeres that contributes to the occurrence of cryogenic fractures during the freezing process [
23,
48]. The cell membrane fluidity is related to the lipid profile and the capacity to support cryo-injuries during cryopreservation process [
48]. The IVPEs possessing has a different lipid profile from their
in vivo derived counterparts [
48,
50] could have cryotolerance enhanced with changes in the lipid metabolism (e.g., TUDCA treatment). Although the evaluation of the lipid content was not assessed in this work, we cannot rule out that TUDCA treatment may have modulated the lipid content of the hatched embryo (down-regulated mRNA abundance of PLIN3 and SREBF2 in T200 group).
In addition, G6PD (Glucose-6-phosphate dehydrogenase) and SLC2A3 (Solute carrier family 2, facilitated glucose transporter member 3) mRNAs were up-regulated in the embryo treated with TUDCA. It was reported that those genes were essential for pre-implantation embryonic development [
58,
59,
60]. Partially, this finding added data to explain how the TUDCA treatment could improve the post-warming hatching rate of vitrified embryos. Since the mammalian hatching process has involved a coordinated trophectoderm activity and is concomitant with the beginning of hypoblast appearance in bovine species [
61], the up-regulation of G6PD and SLC2A3 genes suggest a positive marker after TUDCA treatment.
TUDCA supplementation in IVC was associated with improved embryonic developmental rates in mice [
17,
30], pigs [
18,
28], and cows [
20,
21]. In our experiment, we did not find a significant increase in the rates of blastocyst formation with TUDCA treatments. Similarly, in conditions of low O2 tension (5%), supplementation of 50 µM of TUDCA in IVC of bovine embryos did not modulate embryo competence [
20]. However, embryos that were submitted to high tension O2 (20%) in the IVC showed an increased blastocyst rate in cattle and pigs with the supplementation of, respectively, 50 and 200 µM of TUDCA [
18,
20]. Once again, the potential beneficial effect of TUDCA supplementation seems to be linked with the culture conditions. When stringent condition of the embryo culture is used (e.g., high oxygen tension as source to generate an increase of the reactive oxygen species) the effect of TUDCA to alleviate ER stress was observed [
18,
20] but, that was not the case of our study. Corroborating with our result, some other recent studies have shown that the increase in reactive oxygen species (ROS), due to O2 tension, is closely related to the increase in ER stress in embryos [
20]. In addition, unlike the purpose of our study, TUDCA proved to be beneficial for the development of
in vitro produced embryos in conditions where ER stress was chemically or physically actively induced (e.g., using tunicamycin or heat stress, respectively) [
18,
20,
21,
35,
36,
37].
Complementing these results, when we evaluated the hatching kinetics of embryos treated with TUDCA, a significant reduction in the hatched embryos rate was observed with the T1000 group when compared to the other groups (with or without the addition of TUDCA). Contrary to the reported in mice – which had a positive effect on embryonic development and the newborn rate was described with the addition of 1,000 µM of TUDCA in the culture [
30] - the higher concentration of TUDCA used in our study proved to be toxic to the bovine embryo and impaired its development. Furthermore, the factor already mentioned (O2 tension linked to the TUDCA effect) seems that the species (mouse or cattle) also plays a role on the upper threshold of the beneficial effect of TUDCA (i.e., when the threshold is exceeded, and the toxic effect is observed).
In the analysis of the mRNA abundance involved in ER stress, oxidative stress, metabolism and embryonic quality, the negative effect on hatching rate of the T1000 group was reinforced.
In case of misfolded proteins in the ER lumen, molecular chaperones (HSPD1 and HSPA5) are activated in order to correct this misfolding and maintain homeostasis in the ER [38; 39]. For instance, in cases of ER stress, HSPA5 dissociates from PERK, ATF6, and IRE1 receptors, activating the UPR pathway [
3,
4,
38]. Activated PERK can recognize and phosphorylate eIF2α, which in turn regulates positively the translation of ATF4, an important inducer of CHOP, GADD34, ATF-3, and genes involved in apoptosis [
40]. In the T1000 group, there was an increase on the transcript abundance for HSPD1, ATF6, and EIF2A in hatched embryos. This suggests that the higher concentration of TUDCA of this study paradoxically induced ER stress in the blastocysts. Also, an increase in the gene’s expression involved with oxidative stress (e.g., GFPT2, HMOX1, and TXNRD1) was observed and reinforced the close relationship between ER stress and oxidative stress, where ROS functioned as a mediator of these two events [
41,
42]. Oxidative stress in embryos could lead to DNA damage [
31] and inhibit preimplantation development [
43]. For transcripts involved in lipid metabolism (SREBF2, ELOVL5 and ACACA), there was an up-regulation in embryos of the T1000 group. Crosstalk between ER stress and lipid metabolism was well established [
44,
45,
46,
47]. Several reports indicated that the pathways that regulate UPR also induce the lipid accumulation in the cell. For instance, the ATF6α pathway plays a role in lipid accumulation interacting with the nuclear form of SREBP-2 [
46,
47]. In the literature, the lipid accumulation in embryos is associated with lower rates of embryonic survival after cryopreservation and deviations in the relative abundance of transcripts of important genes for embryonic development [
23,
48]. Additionally, in the corroborating the results, the T1000 group has been shown to increase the transcript abundance for GSK3A (related to embryo development and cell proliferation). GSK3A is a negative regulator in the hormonal control of glucose homeostasis, cell division, proliferation, motility, and survival. In other publications, the highest expression of GSK3A in the embryo is associated with low embryo competence. [
49].
Unlike the T1000 group, the T50 and T200 groups did not significantly affect gene expression in hatched blastocysts when compared to Control, corroborating the results of embryonic development. Although without molecular and cellular evidence of any beneficial effect of TUDCA (T50 and T200 groups), there was no assessment on the pregnancy rate of those embryos (fresh transfer) or the effect of high oxygen culture system.
Author Contributions
Conceptualization, E.M.P. and M.F.G.N; Methodology, E.M.P., C.B.C., F.F.F., P.H.S. and M.F.G.N; Software, E.M.P., C.B.C. and M.F.G.N; Validation, E.M.P., C.B.C., F.F.F., P.H.S., and M.F.G.N; Formal Analysis, E.M.P., C.B.C. and M.F.G.N; Investigation, E.M.P., C.B.C. and M.F.G.N; Resources, M.F.G.N; Data Curation, E.M.P. and M.F.G.N; Writing – Original Draft Preparation, E.M.P. and M.F.G.N; Writing – Review & Editing, E.M.P., C.B.C. and M.F.G.N; Visualization, E.M.P., C.B.C., F.F.F., P.H.S. and M.F.G.N; Supervision, M.F.G.N; Project Administration, E.M.P. and M.F.G.N; Funding Acquisition, M.F.G.N. All authors provided feedback on the manuscript and declare no conflicts of interest. All authors have read and agreed to the published version of the manuscript.